Nyrada Inc. (ASX:NYR) Progresses Phase I Clinical Trial
Nyrada Inc. (ASX:NYR) advances its Phase I clinical trial to the second cohort, anticipating final readouts in Q3 CY2025.
The Hub of Australian Finance News
Nyrada Inc. (ASX:NYR) advances its Phase I clinical trial to the second cohort, anticipating final readouts in Q3 CY2025.
GQG Partners (ASX:GQG) reports a record US$161.9 billion FUM in Q1 2025, driven by significant net inflows and outperforming strategies.
Challenger Gold Limited (ASX:CEL) doubles its Ecuador gold equivalent resource to 9.1Moz and outlines strategic value realization plans.
Dateline Resources (ASX:DTR) secures mining and rare earth exploration rights for its Colosseum Project, enhancing its growth prospects.
Magnetic Resources (ASX:MAU) reports a 97.5% gold recovery at LJN4, highlighting enhanced project potential and cost reductions.
Buru Energy (ASX:BRU) announces significant updates on the Rafael Gas Project, including resource estimates and strategic partnerships.
Aurumin Limited (ASX:AUN) starts RC drilling at the Gwendolyn deposit, aiming to upgrade resources and advance near-term development.
Brightstar Resources (ASX:BTR) commences Fish underground mine operations on schedule and under budget, enhancing its gold production capabilities.
Magnum Mining (ASX:MGU) acquires high-grade US copper-gold projects in Arizona and Idaho, bolstering its mining portfolio.
Waypoint REIT (ASX:WPR) announces a $50 million buyback and expansion of OTR conversions with Viva Energy to boost shareholder value.